Cti Biopharma Corp
CTICDelisted Jun 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000891293
Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Cti Biopharma Corp changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 55 | 50 | −5 |
| Shares | 43.3M | 53.2M | +9.91M (+22.9%) |
| Value | $126.1M | $133.1M | +$7.01M (+5.6%) |
New holders (5)
Institutions that held Cti Biopharma Corp at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sofinnova Investments, Inc. | 171,619 | $429.0K | 0.03% |
| Goldman Sachs Group Inc | 41,558 | $104.0K | 0.00% |
| KBC Group NV | 29,947 | $75.0K | 0.00% |
| Bank of America Corp | 33 | $0 | 0.00% |
| Bedel Financial Consulting, Inc. | 10 | $0 | 0.00% |
Sold out (10)
Institutions that held Cti Biopharma Corp at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Consonance Capital Management LP | 2,512,800 | $7.31M |
| Susquehanna International Group, LLP | 263,140 | $766.0K |
| Citadel Advisors LLC | 211,206 | $615.0K |
| HRT Financial LP | 194,242 | $565.0K |
| ExodusPoint Capital Management, LP | 189,516 | $551.0K |
| Qube Research & Technologies Ltd | 41,593 | $121.0K |
| LMR Partners LLP | 37,769 | $110.0K |
| California Public Employees Retirement System | 28,400 | $83.0K |
| Credit Suisse AG | 14,117 | $41.0K |
| Simplex Trading, LLC | 6,688 | $19.0K |